Liver stellate cells in chronic viral hepatitis: The effect of interferon therapy

Journal of Hepatology

Volumn 24, Issue 3, 1996, Pages 301-307

  Guido, Maria ^a   Rugge, Massimo ^a,d   Chemello, Liliana ^b   Leandro, Gioacchino ^c   Fattovich, Giovanna ^e   Giustina, Giuliano ^b   Cassaro, Mauro ^a   Alberti, Alfredo ^b  

^a Laboratorio Analisi   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Ente Ospedaliero Specializzato G   (Italy)

^d Istituto di Anatomia Umana Normale   (Italy)

^e NONE

Author keywords

fibrosis in viral hepatitis; interferon therapy; liver stellate cell; smooth muscle actin

Indexed keywords

ACTIN; ALPHA INTERFERON; ALPHAN1 INTERFERON; RECOMBINANT ALPHA2A INTERFERON;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; MALE; PRIORITY JOURNAL; SMOOTH MUSCLE; STELLATE CELL; VIRUS HEPATITIS;

EID: 0030003798     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80008-0     Document Type: Article

References (54)

1. Hata R, Ninomiya Y, Nagay Y, Tsukada Y. Biosynthesis of interstitial types of collagen by albumin-producing rat liver parenchymal cell (hepatocyte) clones in culture. Biochemistry 1980; 19: 169-76.
2. Martinez-Hernandez A. The hepatic extracellular matrix: I. Electron immunohistochemical studies in normal rat liver. Lab Invest 1984; 51: 57-74.
3. Clement. B, Grimaud JA, Campion JP, Deugniez Y, Guillouzo A. Cell types involved in collagen and fibronectin production in normal and fibrotic human liver. Hepatology 1986; 6: 225-34.
4. Chojkier M. Hepatocyte collagen production in vivo in normal rats. J Clin Invest 1986; 78: 333-9.
5. Chojkier M, Lyke KD, Filip M. Increased production of collagen in vivo by hepatocytes and non-parenchymal cells in rats with carbon tetrachloride-induced hepatic fibrosis. Hepatology 1988; 8: 808-14.
6. DeLeeuw AM, McCarthy SP, Geerts A, Knock DL. Purified rat liver fat-storing cells in culture divide and contain collagen. Hepatology 1984; 4: 392-403.
7. Friedman SL, Roll FJ, Boyles J, Bissell DM. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci USA 1985; 82: 8681-5.
8. Yokoi Y, Namihisa T, Matsuzaki K, Miyazaki A, Yamaguchi Y Distribution of Ito cells in experimental hepatic fibrosis. Liver 1988; 8: 48-52.
9. Paolucci R, Mancini R, Marucci L, Benedetti A, Jezequel AM, Orlandi F. Immunohistochemical identification of proliferating cells following dimethylnitrosamine-induced liver injury. Liver 1990; 10: 278-81.
10. Tanaka Y, Nouchi T, Yamane M, Irie T, Miyakawa H, Sato C, Marumo F. Phenotypic modulation in lipocytes in experimental liver fibrosis. J Pathol 1991; 164: 273-8.
11. Bhunchet E, Kenjiro W. Role of mesenchymal cell populations in porcine-serum-induced rat liver fibrosis. Hepatology 1992; 16: 1452-73.
12. Nakano M, Lieber CS. Ultrastructure of initial stages of perivenular fibrosis in alcohol-fed baboons. Am J Pathol 1982; 106: 145-55.
13. Okanoue T, Burbige EJ, French SW. The role of the Ito cells in perivenular and intralobular fibrosis in alcoholic hepatitis. Arch Pathol Lab Med 1983; 107: 459-63.
14. French SW, Miyamoto K, Wong K, Jui L, Briere L. Role of the Ito cell in liver parenchymal fibrosis in rats fed alcohol and a high fat-low protein diet. Am J Pathol 1988; 132: 73-85.
15. Milani S, Herbst H, Schuppan D, Hahn EG, Stein H. In situ hybridization for procollagen types I, III, and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in non-parenchymal liver cells. Hepatology 1989; 10: 84-92.
16. Milani S, Herbst H, Schuppan D, Kim KY, Riecken EO, Stein H. Procollagen expression by non-parenchymal rat liver cells in experimental biliary fibrosis. Gastroenterology; 1990; 98: 175-84.
17. Milani S, Herbst H, Schuppan D, Surrenti C, Riecken EO, Stein H. Cellular localization of type I, II and IV procollagen gene transcripts in normal and fibrotic human liver. Am J Pathol 1990; 137: 59-70.
18. Maher JJ, McGuire RF. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest 1990; 86: 1641-8.
19. Geerts A, Lazou JM, De Bleser P, Wisse E. Tissue distribution, quantitation and proliferation kinetics of fat-storing cells in carbon-tetrachloride-injured rat liver. Hepatology 1991; 13: 1193-202.
20. Johnson SJ, Hines JE, Burt AD. Phenotypic modulation of perisinusoidal cells following acute liver injury: a quantitative analysis. Int J Exp Pathol 1992; 73: 765-72.
21. Mancini R, Jezequel AM, Benedetti A, Paolucci F, Trozzi L, Orlandi F. Quantitative analysis of proliferating sinusoidal cells in dimethylnitrosamine-induced cirrhosis. An immunohistochemical study. J Hepatol 1992; 15: 361-66.
22. Kent G, Gay S, Inouye T, Bahu R, Minick OT, Popper H. Vitamin A containing lipocytes and formation of type III collagen in liver injury. Proc Natl Acad Sci USA 1976; 73: 3719-22.
23. Mak KM, Leo MA, Lieber CS. Alcoholic liver injury in baboons: transformation of lipocytes to transitional cells. Gastroenterology 1984; 87: 188-200.
24. Mak KM, Lieber CS. Lipocytes and transitional cells in alcoholic liver disease: a morphometric study. Hepatology 1988; 8: 1027-33.
25. Schmitt-Gräff A, Krüger S, Bochard F, Gabbiani G, Denk H. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol 1991; 138: 1233-42.
26. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986; 103: 2787-96.
27. Geerts A, Vrijsen R, Rauterberg, Burt A, Schellinck, Wisse E. In vitro differentiation of fat-storing cells parallels marked increase of collagen synthesis and secretion. J Hepatol 1989; 9: 59-68.
28. Nouchi T, Tanaka Y, Tsukada T, Sato C, Marumo F. Appearance of α-smooth muscle actin positive cells in hepatic fibrosis. Liver 1991; 11: 100-5.
29. Yamaoka K, Toshihiko N, Marumo F, Sato C. α-Smooth muscle actin expression in normal and fibrotic human livers. Dig Dis Sci 1993; 8: 1473-9.
30. Matsuoka M, Pham NT, Tsukamoto H. Differential effects of interleukin-lα, tumor necrosis factor α, and transforming growth factor β1 on cell proliferation and collagen formation by cultured fat-storing cells. Liver 1988; 9: 71-8.
31. Bachem MG, Riess U, Gressner AM. Liver fat-storing cell proliferation is stimulated by epidermal growth factor/transforming growth factor alpha and inhibited by transforming growth factor beta. Biochem Biophys Res Commun 1989; 162: 708-14.
32. Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. Hepatology 1991; 13: 364-75.
33. Friedmann SL. The molecular basis for Kupffer cell/lipocyte interaction. In: Gressner AM, Ramadori G eds. Molecular and Cell Biology of Liver Fibrogenesis. London: Kluwer Academic, 1992; 358-92.
34. Peterson TC, Isbrucker RA. Fibroproliferation in liver disease: role of monocyte factors. Hepatology 1992; 15: 191-7.
35. Bachem MG, Meyer D, Schäfer W, Riess U, Melchior R, Sell KM, Gressner AM. The response of rat liver perisinusoidal lipocytes to polypeptide growth regulator changes with their transdifferentiation into myofibroblast-like cells in culture. J Hepatol 1993; 18: 40-52.
36. Rockey DC, Maher JJ, Jarnagin WR, Gabbiani G, Friedman SL. Inhibition of rat hepatic lipocyte activation in culture by interferon-γ. Hepatology 1992; 16: 776-84.
37. Curto P, Benedetti A, Svegliati Baroni G, Mancini R, Di Sario A, Jezequel AM, Orlandi F. Interferon-gamma decreases in vivo lipocyte proliferation and activation and reduces liver fibrosis (Abstract). Ital J Gastroenterol 1994, 26: 199.
38. Fattovich G, Brollo L, Boscaro S, Pontisso P, Giustina G, Criscuolo D, Maladorno D, Alberti A, Realdi G, Ruol A. Longterm effect of low dose recombinant interferon therapy in patients with chronic hepatitis. Br J Hepatol 1989; 9: 331-7.
39. Fattovich G, Farci P, Rugge M Brollo L, Mandas A, Pontisso P, Giustina G, Lai ME, Belussi F, Busatto G, Balestrieri A, Ruol A, Alberti A. A randomized controlled trial of lymphoblastoid interferon-α in patients with chronic hepatitis B lacking HBeAg. Hepatology 1992; 15: 584-9.
40. Alberti A, Chemello L, Bonetti P, Casarin C, Diodati G, Cavalletto L, Cavalletto D, Frezza M, Donada C, Belussi F, Casarin P, Pozzato G, Ruol A & TVVH Study Group. Treatment with interferon(s) of community acquired chronic hepatitis and cirrhosis type C. J Hepatol 1993; 17 (Suppl.3): S123-S6.
41. 2a: results of a randomized controlled clinical trial. Hepatology 1994; 19: 1-5.
42. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13: 372-4.
43. International Group. Acute and chronic hepatitis revisited. Lancet 1977; 2: 914-9.
44. Bianchi L, Spichtin HP, Gudat F. Chronic hepatitis. In: McSween RNM, Anthony PP, Scheuer PJ, eds. Pathology of the Liver. Edinburgh, London, Melbourne, and New York: Churchill Livingstone, 1987: 310-41.
45. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 1989; 321: 1506-10.
46. Realdi G, Fattovich G, Pastore G, Caredda F, Noventa F, Santantonio T, Moroni M, Criscuolo D, Maladorno D, Rugge M, Dienes HP. Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicenter study. J Hepatol 1990; 11: S129-32.
47. Castilla A, Prieto J, Fausto N. Transforming growth factor β1 and α in chronic liver disease. Effect of interferon alpha therapy. N Engl J Med 1991; 324: 933-40.
48. Capra F, Casaril M, Gabrielli GB, Tognella P, Rizzi A, Dolci L, Colombari R, Mezzelani P, Corrocher R, De Sandre G. α-interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markers. J Hepatol 1993; 18: 112-8.
49. 2b, therapy reduces liver fibrosis in chronic non-A nonB hepatitis: a quantitative histological evaluation. Hepatology 1993; 18: 1344-9.
50. Camps J, Castilla A, Ruiz J, Civeira MP, Prieto J. Randomized trial of lymphoblastoid alpha-interferon in chronic hepatitis C. Effects on inflammation, fibrogenesis and viremia. J Hepatol 1993; 17: 390-6.
51. Mathew J, Hines JE, James OFW, Burt AD. Non-parenchymal cell responses in paracetamol (acetaminophen)-induced liver injury. J Hepatol 1994; 20: 537-41.
52. Enzan H, Himeno H, Iwamura S, Saibara T, Onishi S, Yamamoto Y, Hara H. Immunohistochemical identification of Ito cells and their myofibroblastic transformation in adult human liver. Virchows Arch 1994; 424: 249-56.
53. Burt AD. CL Oakley lecture (1993): cellular and molecular aspects of hepatic fibrosis. J Pathol 1993; 170: 105-14.
54. Gressner AM, Lotfi S, Gressner G, Lahme B. Identification and partial characterization of a hepatocyte-derived factor promoting proliferation of fat-storing cells (parasinusoidal lipocytes). Hepatology 1992; 16: 1250-66.